C.R. Bard Inc. (BCR) Plans $0.26 Quarterly Dividend
C.R. Bard Inc. (NYSE:BCR) declared a quarterly dividend on Wednesday, October 12th. Shareholders of record on Monday, October 24th will be given a dividend of 0.26 per share on Friday, November 4th. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.48%.
C.R. Bard (NYSE:BCR) traded up 0.03% on Wednesday, hitting $217.82. 536,144 shares of the company were exchanged. C.R. Bard has a 52 week low of $172.21 and a 52 week high of $239.43. The company has a 50 day moving average price of $222.08 and a 200-day moving average price of $220.65. The stock has a market capitalization of $16.00 billion, a P/E ratio of 50.66 and a beta of 0.50.
C.R. Bard (NYSE:BCR) last issued its quarterly earnings data on Tuesday, July 26th. The company reported $2.54 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.47 by $0.07. The business had revenue of $931.50 million for the quarter, compared to the consensus estimate of $915.22 million. C.R. Bard had a net margin of 9.20% and a return on equity of 48.43%. The company’s quarterly revenue was up 8.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.27 EPS. On average, equities analysts expect that C.R. Bard will post $10.17 earnings per share for the current fiscal year.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/12/c-r-bard-inc-bcr-plans-0-26-quarterly-dividend.html
A number of analysts have recently weighed in on the stock. JPMorgan Chase & Co. upped their target price on shares of C.R. Bard from $214.00 to $225.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 27th. Morgan Stanley reaffirmed a “hold” rating and issued a $240.00 target price on shares of C.R. Bard in a research report on Thursday, July 28th. Citigroup Inc. increased their price objective on shares of C.R. Bard from $241.00 to $265.00 and gave the company a “buy” rating in a research report on Wednesday, July 27th. Deutsche Bank AG upped their target price on shares of C.R. Bard from $234.00 to $240.00 and gave the company a “hold” rating in a research note on Wednesday, July 27th. Finally, Evercore ISI assumed coverage on shares of C.R. Bard in a research note on Thursday, September 15th. They set a “buy” rating and a $235.00 target price on the stock. Thirteen equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $233.00.
In other news, VP Betty D. Larson sold 4,032 shares of C.R. Bard stock in a transaction on Monday, September 19th. The stock was sold at an average price of $225.33, for a total transaction of $908,530.56. Following the completion of the sale, the vice president now directly owns 10,298 shares in the company, valued at $2,320,448.34. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Chairman Timothy M. Ring sold 92,293 shares of C.R. Bard stock in a transaction on Wednesday, September 28th. The stock was sold at an average price of $227.81, for a total value of $21,025,268.33. Following the sale, the chairman now owns 145,876 shares of the company’s stock, valued at $33,232,011.56. The disclosure for this sale can be found here. 0.97% of the stock is owned by corporate insiders.
Hedge funds have recently added to or reduced their stakes in the company. BlackRock Investment Management LLC increased its stake in C.R. Bard by 3.2% in the second quarter. BlackRock Investment Management LLC now owns 180,066 shares of the company’s stock valued at $42,344,000 after buying an additional 5,576 shares during the period. BlackRock Institutional Trust Company N.A. raised its stake in shares of C.R. Bard by 7.8% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 2,409,718 shares of the company’s stock worth $566,669,000 after buying an additional 174,993 shares during the last quarter. BlackRock Japan Co. Ltd raised its stake in shares of C.R. Bard by 21.8% in the second quarter. BlackRock Japan Co. Ltd now owns 120,617 shares of the company’s stock worth $28,364,000 after buying an additional 21,615 shares in the last quarter. Tredje AP fonden raised its stake in shares of C.R. Bard by 717.8% in the second quarter. Tredje AP fonden now owns 9,650 shares of the company’s stock worth $2,269,000 after buying an additional 8,470 shares in the last quarter. Finally, Commonwealth Bank of Australia raised its stake in shares of C.R. Bard by 8.2% in the second quarter. Commonwealth Bank of Australia now owns 5,235 shares of the company’s stock worth $1,231,000 after buying an additional 397 shares in the last quarter. Institutional investors and hedge funds own 87.90% of the company’s stock.
About C.R. Bard
C. R. Bard, Inc (Bard) and its subsidiaries are engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company sells its products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities.
Receive News & Ratings for C.R. Bard Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for C.R. Bard Inc. and related companies with MarketBeat.com's FREE daily email newsletter.